Noto et al., 2014 - Google Patents
The urinary metabolomics profile of an Italian autistic children population and their unaffected siblingsNoto et al., 2014
View PDF- Document ID
- 4208810979084331387
- Author
- Noto A
- Fanos V
- Barberini L
- Grapov D
- Fattuoni C
- Zaffanello M
- Casanova A
- Fenu G
- De Giacomo A
- De Angelis M
- Moretti C
- Papoff P
- Ditonno R
- Francavilla R
- Publication year
- Publication venue
- The Journal of Maternal-Fetal & Neonatal Medicine
External Links
Snippet
Objective: A supervised multivariate model to classify the metabolome alterations between autistic spectrum disorders (ASD) patients and controls, siblings of autistic patients, has been realized and used to realize a network model of the ASD patients' metabolome …
- 230000002485 urinary 0 title abstract description 23
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Noto et al. | The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings | |
Guijas et al. | Metabolomics activity screening for identifying metabolites that modulate phenotype | |
Germain et al. | Comprehensive circulatory metabolomics in ME/CFS reveals disrupted metabolism of acyl lipids and steroids | |
Yang et al. | Potential metabolite markers of schizophrenia | |
West et al. | Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children | |
Ouyang et al. | 1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus | |
Germain et al. | Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology | |
Cocco et al. | 1H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis | |
Sarafidis et al. | Urine metabolomics in neonates with late-onset sepsis in a case-control study | |
Wellington et al. | Metabolic trajectories following contrasting prudent and Western diets from food provisions: identifying robust biomarkers of short-term changes in habitual diet | |
Mussap et al. | Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites | |
Rangel-Huerta et al. | Metabolic profiling in children with autism spectrum disorder with and without mental regression: Preliminary results from a cross-sectional case–control study | |
Cui et al. | Metabolomics and incident dementia in older Chinese adults: The Shanghai Aging Study | |
Nam et al. | Towards standardization of data normalization strategies to improve urinary metabolomics studies by GC× GC-TOFMS | |
Ma et al. | Characterizing semen abnormality male infertility using non-targeted blood plasma metabolomics | |
Zhang et al. | Serum metabolomic profiling identifies characterization of non-obstructive azoospermic men | |
Monteleone et al. | Metabolomics signatures of acutely ill and short-term weight recovered women with anorexia nervosa | |
Qureshi et al. | Multivariate analysis of fecal metabolites from children with autism spectrum disorder and gastrointestinal symptoms before and after microbiota transfer therapy | |
Zhang et al. | Discovering biomarkers in bladder cancer by metabolomics | |
Sundekilde et al. | An integrated multi-omics analysis defines key pathway alterations in a diet-induced obesity mouse model | |
Cai et al. | Tumor tissue-specific biomarkers of colorectal cancer by anatomic location and stage | |
Li et al. | Metabolomics-based study of potential biomarkers of sepsis | |
Khan et al. | Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder | |
Yilmaz et al. | Metabolic profiling of CSF from people suffering from sporadic and LRRK2 Parkinson’s disease: a pilot study | |
Lawler et al. | Characterizing the plasma metabolome during 14 days of live‐high, train‐low simulated altitude: A metabolomic approach |